MoneyWorks4Me

Eiko Lifesciences - Quaterly Results

09 May 2023 Evaluate
The March 2023 quarter revenue stood at Rs. 65.94 millions, up 24.60% as compared to Rs. 52.92 millions during the corresponding quarter last year.The Profit  for the quarter ended March 2023 of  Rs. 2.83  millions  grew by 91.22% from Rs. 1.48 millions.The company reported a good operating profit of 5.73 millions compared to 4.55 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 65.94 52.92 24.60 183.21 254.32 -27.96 183.21 254.32 -27.96
Other Income 2.08 2.05 1.46 8.55 6.53 30.93 8.55 6.53 30.93
PBIDT 5.73 4.55 25.93 18.10 19.68 -8.03 18.10 19.68 -8.03
Interest 0.35 1.06 -66.98 1.50 4.64 -67.67 1.50 4.64 -67.67
PBDT 5.38 3.49 54.15 16.60 15.04 10.37 16.60 15.04 10.37
Depreciation 1.60 1.56 2.56 6.33 5.62 12.63 6.33 5.62 12.63
PBT 3.78 1.93 95.85 10.27 9.42 9.02 10.27 9.42 9.02
TAX 0.95 0.45 111.11 2.57 2.36 8.90 2.57 2.36 8.90
Deferred Tax 0.47 0.45 4.44 2.09 2.34 -10.68 2.09 2.34 -10.68
PAT 2.83 1.48 91.22 7.70 7.06 9.07 7.70 7.06 9.07
Equity 83.16 83.16 0.00 83.16 83.16 0.00 83.16 83.16 0.00
PBIDTM(%) 8.69 8.60 1.07 9.88 7.74 27.67 9.88 7.74 27.67
Peers
Company Name CMP
Godrej Industries 1021.20
SRF 2490.00
BASF India 3411.40
Pidilite Inds. 1470.00
Tata Chemicals 607.90
View more..